SeaStar Medical, Inc.
Immunomodulation technology to prevent cytokine storm in sepsis and critical illness
- Sector
- Biotech
- Headquarters
- Denver, CO
- Founded
- 2007
- Latest Form D
- $5.3M, Dec 2020
- Total capital
- $35.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $35.4M
- 4 Form D · last Dec 2020
- 70 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 10 pending · first 2020
- Rank in peer group#245 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$5.3M
- Private capital raisedForm D · SEC · 3rd filing$16.4M
- Private capital raisedForm D · SEC · 2nd filing$11.7M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#245 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Eric SchlorffExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 16- GrantedCytopheresis Cartridges And Use ThereofUSPTOUS 12,478,923
- GrantedCytopheresis Cartridges And Use ThereofUSPTOUS 11,866,730
- PendingSelective Cytopheresis Devices And Related Methods ThereofUSPTOApplication 17937632
Show all 16 patent records
- Cytopheresis Cartridges And Use ThereofNov 25, 2025 · US 12,478,923Granted
- Cytopheresis Cartridges And Use ThereofJan 9, 2024 · US 11,866,730Granted
- Selective Cytopheresis Devices And Related Methods ThereofSep 7, 2023 · Application 17937632Pending
- Devices And Methods For Treating Or Preventing Cytokine Release Syndrome And Tumor Lysis SyndromeMay 18, 2023 · Application 18002576Pending
- Devices And Methods For Reducing Rejection Of A Transplanted Organ In A RecipientFeb 2, 2023 · Application 17789955Pending
- Cartridge And Method For Increasing Myocardial FunctionSep 13, 2022 · US 11,439,739Granted
- Device And Method For Preparing A Donor Organ For TransplantationSep 1, 2022 · Application 17597983Pending
- Cytopheresis Cartridges And Use ThereofSep 14, 2021 · US 11,118,162Granted
- Cartridge And Method For Increasing Myocardial FunctionJul 28, 2020 · US 10,722,637Granted
- Cartridge And Method For Increasing Myocardial FunctionJun 30, 2020 · US 10,695,482Granted
- Devices And Methods For Treating Or Preventing Cytokine Release Syndrome And Tumor Lysis SyndromeApplication 63045503Pending
- Devices And Methods For Reducing Rejection Of A Transplanted Organ In A RecipientApplication 62955635Pending
- Device And Method For Preparing A Donor Organ For TransplantationApplication PCTUS2020044413Pending
- Devices And Methods For Reducing Rejection Of A Transplanted Organ In A RecipientApplication PCTUS2020067527Pending
- Devices And Methods For Treating Or Preventing Cytokine Release Syndrome And Tumor Lysis SyndromeApplication PCTUS2021039301Pending
- Device And Method For Preparing A Donor Organ For TransplantationApplication 62881695Pending
Related companies, and why
- Earli Inc.Similar federal contract value in Biotech · null in contracts
- Bugworks Research, Inc.Similar federal contract value in Biotech · null in contracts
- Scholar RockSimilar federal contract value in Biotech · null in contracts
- SynthorxSimilar federal contract value in Biotech · null in contracts
- Contineum TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Pulmatrix Operating Company, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .